Kairos Pharma Wins Biotech Breakthrough Awards for ENV-105
Kairos Pharma's lead candidate ENV-105 won the Cancer Immunology Solution award for targeting drug resistance. The company announced positive interim efficacy data from its Phase 2 mCRPC trial.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed